Following Judge Vince Chhabria’s denial of a motion for preliminary approval of a settlement in the consolidated Roundup Northern District of California
Judge Rejects Settlement to Resolve Future Roundup Cancer Claims courthousenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from courthousenews.com Daily Mail and Mail on Sunday newspapers.
May 27, 2021 Bayer announced today a series of actions it plans to implement following the denial of the motion to preliminarily approve the Roundup class settlement agreement, designed to address
U.S. Court Rejects Bayer s $2 Bln Settlement For Future Roundup Claims
LEVERKUSEN (dpa-AFX) - A federal judge rejected Bayer s (BAYZF.PK, BAYRY.PK, BYR.L) $2 billion Roundup settlement, saying in an order it would not adequately address the concerns of families who may later be diagnosed with non-Hodgkin s lymphoma. Meanwhile, Bayer announced five-point plan to effectively address potential future Roundup claims.
Bayer said in February that it reached $2 billion agreement with plaintiffs attorneys to settle future lawsuits over claims that its Roundup weedkiller causes cancer. The settlement would provide future plaintiffs, who contract non-Hodgkin lymphoma after using Roundup, up to $200,000 in compensation.
Plan is in response to denial by federal judge of Roundup class settlement agreement By
5/27/2021 Bayer officials say this new package of measures, which combine a number of legal and commercial actions, is designed to help the company achieve a level of risk mitigation that is comparable to the previously proposed national class solution. . The court’s decision closes the door on an MDL (multidistrict litigation) court-supervised national class solution to manage potential future litigation, which would have been the fairest, most efficient mechanism for all parties, said Bayer officials in a news release. Still, officials for Bayer say it has legal and commercial options that together will achieve a similar result in mitigating future litigation risk, which it will pursue as quickly as possible.